INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
11-year-old Greenwood boy dies in home
Authorities in central Indiana are investigating the death of an 11-year-old boy.
Should Ind. file lawsuit against immigration?
Indiana leaders could take possible legal action against President Obama's administration following his announcement on immigration action.
Indiana DNR offers camping gift cards
Indiana residents stumped by what holiday gift to buy a friend or relative who loves the great outdoors now have the option of reserving them…
Off-duty state trooper extinguishes house fire
An off-duty Indiana State Trooper in Wayne County saved a home from going up in flames on Saturday.
Dozens gather at service for slain aid worker
Dozens of people gathered Saturday night to honor an Indiana aid worker executed by Islamic State militants.
Friends, family mourn teens killed Thursday
Church members came together in remembrance Saturday for two young men killed this week on the northeast side.